AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
LANREOTIDE
11 registrations across 2 African markets— 8 active
Markets with LANREOTIDE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| SOMATULINE LP Solution injectable / 60 mg | 🇹🇳Tunisia | IPSEN Pharma | expired | Mar 2017 |
| SOMATULINE LP Solution injectable / 90 mg | 🇹🇳Tunisia | IPSEN Pharma | expired | Mar 2017 |
| SOMATULINE LP Solution injectable / 120 mg | 🇹🇳Tunisia | IPSEN Pharma | expired | Mar 2017 |
| SOMATULINE LP 120 MG SOLUTION INJECTABLE LP | 🇲🇦Morocco | — | active | — |
| SOMATULINE LP 120 MG SOLUTION INJECTABLE LP | 🇲🇦Morocco | — | active | — |
| SOMATULINE LP 30 MG SOLUTION INJECTABLE | 🇲🇦Morocco | — | active | — |
| SOMATULINE LP 30 MG SOLUTION INJECTABLE | 🇲🇦Morocco | — | active | — |
| SOMATULINE LP 60MG SOLUTION INJECTABLE LP | 🇲🇦Morocco | — | active | — |
| SOMATULINE LP 60MG SOLUTION INJECTABLE LP | 🇲🇦Morocco | — | active | — |
| SOMATULINE LP 90 MG SOLUTION INJECTABLE LP | 🇲🇦Morocco | — | active | — |
| SOMATULINE LP 90 MG SOLUTION INJECTABLE LP | 🇲🇦Morocco | — | active | — |
LANREOTIDE in Africa — Regulatory Overview
LANREOTIDE is registered across 2 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Morocco, Tunisia. AfricaRegulatory refreshes this data daily from official government sources.
Of the 11 registrations, 8 (73%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.